OTC Markets OTCQX - Delayed Quote USD
CSL Limited (CMXHF)
153.34
0.00
(0.00%)
At close: April 23 at 4:00:00 PM EDT
Insider Purchases Last 6 Months
Shares | Transactions | |
---|---|---|
Purchases | 0 | 0 |
Sales | -- | 0 |
Net Shares Purchased (Sold) | 0 | 0 |
Total Insider Shares Held | 1.46M | -- |
% Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
Shares | |
---|---|
Net Shares Purchased (Sold) | -- |
% Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
Insider | Transaction | Type | Value | Date |
---|---|---|---|---|
Clark (Megan Elizabeth) Independent Non-Executive Director | Purchase at price 159.59 per share. | Direct | 31,917 | Mar 17, 2025 |
Clark (Megan Elizabeth) Independent Non-Executive Director | -- | Direct | -- | Feb 19, 2025 |
Cuthbertson (Robert Andrew) Independent Non-Executive Director | -- | Direct | -- | Feb 19, 2025 |
Hewson (Carolyn Judith) Independent Non-Executive Director | -- | Direct | -- | Feb 19, 2025 |
Lewis (Samantha Louise) Independent Non-Executive Director | -- | Direct | -- | Feb 19, 2025 |
McDonald (Marie) Independent Non-Executive Director | -- | Direct | -- | Feb 19, 2025 |
McNamee (Brian Anthony) Independent Non-Executive Chairman | -- | Direct | -- | Feb 19, 2025 |
Watkins (Alison Mary) Independent Non-Executive Director | -- | Direct | -- | Feb 19, 2025 |
McKenzie (Paul F) Chief Executive Officer | Sale at price 188.97 per share. | Direct | 755,891 | Oct 31, 2024 |
McKenzie (Paul F) Chief Executive Officer | Sale at price 0.05 per share. | Direct | 204 | Sep 3, 2024 |
McKenzie (Paul F) Chief Executive Officer | -- | Direct | -- | Sep 2, 2024 |
Clark (Megan Elizabeth) Independent Non-Executive Director | -- | Direct | -- | Aug 16, 2024 |
Cuthbertson (Robert Andrew) Independent Non-Executive Director | -- | Direct | -- | Aug 16, 2024 |
Hewson (Carolyn Judith) Independent Non-Executive Director | -- | Direct | -- | Aug 16, 2024 |
Lewis (Samantha Louise) Independent Non-Executive Director | -- | Direct | -- | Aug 16, 2024 |
Maskell (Duncan John Ph.D.) Independent Non-Executive Director | -- | Direct | -- | Aug 16, 2024 |
McDonald (Marie) Independent Non-Executive Director | -- | Direct | -- | Aug 16, 2024 |
McNamee (Brian Anthony) Independent Non-Executive Chairman | -- | Direct | -- | Aug 16, 2024 |
Watkins (Alison Mary) Independent Non-Executive Director | -- | Direct | -- | Aug 16, 2024 |
Schmeltz (Andy) Other Executive | -- | Direct | -- | Jun 30, 2024 |
Linton (Joy) Chief Financial Officer | -- | Direct | -- | Jun 30, 2024 |
Clark (Megan Elizabeth) Independent Non-Executive Director | -- | Direct | -- | Feb 16, 2024 |
Cuthbertson (Robert Andrew) Independent Non-Executive Director | -- | Direct | -- | Feb 16, 2024 |
Hewson (Carolyn Judith) Independent Non-Executive Director | -- | Direct | -- | Feb 16, 2024 |
Maskell (Duncan John Ph.D.) Independent Non-Executive Director | -- | Direct | -- | Feb 16, 2024 |
McDonald (Marie) Independent Non-Executive Director | -- | Direct | -- | Feb 16, 2024 |
McNamee (Brian Anthony) Chairman of the Board | -- | Direct | -- | Feb 16, 2024 |
Watkins (Alison Mary) Independent Non-Executive Director | -- | Direct | -- | Feb 16, 2024 |
Clark (Megan Elizabeth) Independent Non-Executive Director | Purchase at price 150.11 per share. | Direct | 31,522 | Oct 20, 2023 |
Brook (Bruce Robert) Former | -- | Direct | -- | Oct 11, 2023 |
McKenzie (Paul F) Chief Executive Officer | -- | Direct | -- | Sep 1, 2023 |
McKenzie (Paul F) Chief Executive Officer | Sale at price 173.25 per share. | Direct | 235,787 | Sep 1, 2023 |
McNamee (Brian Anthony) Chairman of the Board | -- | Indirect | -- | Aug 23, 2023 |
Clark (Megan Elizabeth) Independent Non-Executive Director | -- | Direct | -- | Aug 21, 2023 |
Cuthbertson (Robert Andrew) Independent Non-Executive Director | -- | Direct | -- | Aug 21, 2023 |
Hewson (Carolyn Judith) Independent Non-Executive Director | -- | Direct | -- | Aug 21, 2023 |
Maskell (Duncan John Ph.D.) Independent Non-Executive Director | -- | Direct | -- | Aug 21, 2023 |
McDonald (Marie) Independent Non-Executive Director | -- | Direct | -- | Aug 21, 2023 |
McNamee (Brian Anthony) Chairman of the Board | -- | Direct | -- | Aug 21, 2023 |
Brook (Bruce Robert) Independent Non-Executive Director | -- | Direct | -- | Aug 21, 2023 |
Watkins (Alison Mary) Independent Non-Executive Director | -- | Direct | -- | Aug 21, 2023 |
Clark (Megan Elizabeth) Independent Non-Executive Director | Purchase at price 174.19 per share. | Direct | 38,322 | Aug 18, 2023 |
Linton (Joy) Chief Financial Officer | -- | Direct | -- | Jun 30, 2023 |
Related Tickers
G51.F Genscript Biotech Corporation
1.2150
+2.53%
XOMAP XOMA Royalty Corporation
25.72
-0.49%
BNTC Benitec Biopharma Inc.
13.66
-0.91%
LEGN Legend Biotech Corporation
34.30
-0.52%
PBYI Puma Biotechnology, Inc.
3.0300
+0.66%
ADPT Adaptive Biotechnologies Corporation
7.38
+5.28%
YMAB Y-mAbs Therapeutics, Inc.
4.1200
-3.29%
ADAP Adaptimmune Therapeutics plc
0.2602
-0.80%
CRVO CervoMed Inc.
9.02
+2.50%
CNTB Connect Biopharma Holdings Limited
0.6800
-0.15%